Feasibility and outcomes of a goal-directed physical therapy program for patients with metastatic breast cancer

Autor: Neil K. Aaronson, J. G. Schrama, Martijn M. Stuiver, Gabe S. Sonke, M. J. Van der Vorst, Edwin Geleijn, Suzan Vrijaldenhoven, S. D. Bakker, Wim G. Groen, Rachel Verbeek, A. A. van Zweeden, M. R. ten Tusscher, Inge R. H. M. Konings

Publikováno v: Groen, W G, ten Tusscher, M R, Verbeek, R, Geleijn, E, Sonke, G S, Konings, I R, van der Vorst, M J, van Zweeden, A A, Schrama, J G, Vrijaldenhoven, S, Bakker, S D, Aaronson, N K & Stuiver, M M 2021, ' Feasibility and outcomes of a goal-directed physical therapy program for patients with metastatic breast cancer ', Supportive Care in Cancer, vol. 29, no. 6, pp. 3287-3298 . https://doi.org/10.1007/s00520-020-05852-9, https://doi.org/10.1007/s00520-020-05852-9
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 29, 3287-3298. Springer Verlag
Supportive Care in Cancer, 29(6), 3287-3298. Springer Verlag
Supportive care in cancer, 29(6), 3287-3298. Springer Verlag

PURPOSE: To evaluate the feasibility and outcomes of a tailored, goal-directed, and exercise-based physical therapy program for patients with metastatic breast cancer (MBC).METHODS: This was an observational, uncontrolled feasibility study. The physi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08e8d228b6ef1bac86741f745893ab7c
https://doi.org/10.1007/s00520-020-05852-9

Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch Breast Cancer Trialists' Group

Autor: Carolien H. Smorenburg, H. van Tinteren, A.E. van Leeuwen-Stok, M. Los, Johan W.R. Nortier, Jürgen Braun, Marije E. Hamaker, J G Schrama, Caroline Seynaeve, A.N.M. Wymenga, E. Maartense, H de Graaf, S. de Groot, F.E. de Jongh

Publikováno v: The Breast, 23(1), 81-87
Breast, 23(1), 81-87. Churchill Livingstone

Aim: To evaluate the association between baseline comprehensive geriatric assessment (CGA) or the Groningen Frailty Indicator (GFI) and toxicity in elderly metastatic breast cancer (MBC) patients treated with first-line palliative chemotherapy. Patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c85b4b2f17cb7ff7b12cfdf781bb8a71
https://doi.org/10.1016/j.breast.2013.11.004

A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

Autor: C.J.A. Punt, Annemieke Cats, Jolien Tol, Linda Mol, Ninja Antonini, Miriam Koopman, Frans L. G. Erdkamp, C.J. Rodenburg, Geert Jan Creemers, J. G. Schrama, A. Vos

Publikováno v: Annals of Oncology, 19, 734-8
Annals of Oncology, 19, 4, pp. 734-8
Annals of oncology, 19(4), 734-738. Oxford University Press

Item does not contain fulltext BACKGROUND: Targeting the vascular endothelial growth factor or the epidermal growth factor receptor (EGFR) has shown efficacy in advanced colorectal cancer (ACC), but no data are available on the combination of these s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fb5ef64e13e5ce6e4d19d70e741101f
https://doi.org/10.1093/annonc/mdm607

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients

Autor: de Elisabeth G. E. Vries, Femke E. Froklage, J G Schrama, M. de Bruin, Michael Hauptmann, M.J. van de Vijver, Esther H. Lips, Sjoerd Rodenhuis, Marieke A. Vollebergh, Sten Cornelissen, Jelle Wesseling, Marjanka K. Schmidt, M. J. Holtkamp, Petra M. Nederlof, Sabine C. Linn, H. van Tinteren, E. H. van Beers, L. F. A. Wessels

Publikováno v: Annals of Oncology
Annals of oncology, 22(7), 1561-1570. Oxford University Press
Annals of Oncology, 22(7), 1561-1570. Oxford University Press

Background: Breast cancer cells deficient for BRCA1 are hypersensitive to agents inducing DNA double-strand breaks (DSB), such as bifunctional alkylators and platinum agents. Earlier, we had developed a comparative genomic hybridisation (CGH) classif

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dc74b75a46bb8c9ac160440f3b88c4e
https://pubmed.ncbi.nlm.nih.gov/21135055

Palliative chemotherapy after failure of high-dose chemotherapy in breast cancer--toxicity and efficacy

Autor: J G, Schrama, M M, de Boer, J W, Baars, J H, Schornagel, S, Rodenhuis

Publikováno v: Anticancer research. 23(3C)

We evaluated the toxicity and efficacy of the first palliative chemotherapy regimen after failure of high-dose chemotherapy in 148 patients with primary or metastatic breast cancer treated with high-dose chemotherapy (one full dose CTC, (cyclophospha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::07b426654e14997b1d819f77b52137af
https://pubmed.ncbi.nlm.nih.gov/12926115